128.75
price down icon5.71%   -7.80
after-market アフターアワーズ: 128.75
loading
前日終値:
$136.55
開ける:
$136.16
24時間の取引高:
886.73K
Relative Volume:
1.01
時価総額:
$8.33B
収益:
$74.06M
当期純損益:
$-114.71M
株価収益率:
-71.37
EPS:
-1.8039
ネットキャッシュフロー:
$-117.90M
1週間 パフォーマンス:
-10.42%
1か月 パフォーマンス:
-9.86%
6か月 パフォーマンス:
+24.12%
1年 パフォーマンス:
+70.01%
1日の値動き範囲:
Value
$126.39
$136.56
1週間の範囲:
Value
$126.39
$152.19
52週間の値動き範囲:
Value
$73.08
$160.81

Protagonist Therapeutics Inc Stock (PTGX) Company Profile

Name
名前
Protagonist Therapeutics Inc
Name
セクター
Healthcare (1052)
Name
電話
(510) 474-0170
Name
住所
7707 GATEWAY BLVD., SUITE 140, NEWARK, CA
Name
職員
132
Name
Twitter
Name
次回の収益日
2026-11-05
Name
最新のSEC提出書
Name
PTGX's Discussions on Twitter

Compare PTGX vs VRTX, MRNA, REGN, ARGX, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
PTGX icon
PTGX
Protagonist Therapeutics Inc
128.75 8.33B 74.06M -114.71M -117.90M -1.8039
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
499.74 126.66B 12.34B 4.34B 3.71B 16.87
MRNA icon
MRNA
Moderna Inc
218.01 87.04B 2.23B -3.19B -1.60B -8.1462
REGN icon
REGN
Regeneron Pharmaceuticals Inc
790.74 81.41B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
819.14 51.51B 4.16B 1.29B 734.26M 19.58
ONC icon
ONC
Beone Medicines Ltd Adr
369.06 41.75B 5.76B 514.49M 1.10B 4.4813

Protagonist Therapeutics Inc Stock (PTGX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-10-12 開始されました UBS Buy
2026-08-10 アップグレード Goldman Neutral → Buy
2026-05-21 開始されました Wolfe Research Outperform
2025-09-17 開始されました Barclays Overweight
2025-09-12 開始されました Leerink Partners Outperform
2025-06-17 開始されました Citigroup Buy
2024-12-06 開始されました BMO Capital Markets Outperform
2024-12-06 開始されました Goldman Neutral
2024-11-05 開始されました Wedbush Outperform
2024-09-24 開始されました TD Cowen Buy
2024-09-09 開始されました Truist Buy
2023-10-30 開始されました CapitalOne Overweight
2023-05-25 再開されました Jefferies Buy
2022-08-25 開始されました JMP Securities Mkt Outperform
2022-02-11 開始されました BTIG Research Buy
2021-10-12 アップグレード JP Morgan Neutral → Overweight
2021-10-11 アップグレード Northland Capital Market Perform → Outperform
2021-09-20 ダウングレード JP Morgan Overweight → Neutral
2021-05-24 開始されました JMP Securities Mkt Outperform
2021-05-24 開始されました Northland Capital Outperform
2021-01-06 開始されました JP Morgan Overweight
2020-12-16 開始されました Piper Sandler Overweight
2020-09-18 繰り返されました H.C. Wainwright Buy
2020-07-15 開始されました Jefferies Buy
2020-05-18 繰り返されました H.C. Wainwright Buy
2019-07-08 開始されました H.C. Wainwright Buy
2019-05-09 アップグレード Stifel Hold → Buy
2018-12-06 開始されました Nomura Buy
2018-01-29 開始されました Stifel Buy
2017-07-21 開始されました BTIG Research Buy
すべてを表示

Protagonist Therapeutics Inc (PTGX) 最新ニュース

pulisher
Oct 15, 2026

Protagonist Therapeutics (PTGX) Upgraded to Strong Buy: Here's What You Should Know - Zacks Investment Research

Oct 15, 2026
pulisher
Oct 14, 2026

Protagonist Therapeutics (PTGX) Could Be 21% Undervalued As Royalty Funded Narrative Builds - Simply Wall Street

Oct 14, 2026
pulisher
Oct 14, 2026

Protagonist Therapeutics (NASDAQ:PTGX) Raised to "Strong-Buy" at UBS Group - MarketBeat

Oct 14, 2026
pulisher
Oct 13, 2026

UBS sets USD 184.00 target for Protagonist Therapeutics stock - ad-hoc-news.de

Oct 13, 2026
pulisher
Oct 12, 2026

UBS Initiates Coverage on Protagonist Therapeutics With Buy Rating, $184 Price Target - Moomoo

Oct 12, 2026
pulisher
Oct 12, 2026

Nektar, Protagonist, Shattuck are Leerink top picks in emerging immunology - Seeking Alpha

Oct 12, 2026
pulisher
Oct 12, 2026

Protagonist Therapeutics (NASDAQ:PTGX) Stock Keeps "Outperform" Rating at Leerink Partners - MarketBeat

Oct 12, 2026
pulisher
Oct 12, 2026

UBS initiates Protagonist Therapeutics stock with buy rating on drug potential - Investing.com

Oct 12, 2026
pulisher
Oct 10, 2026

Protagonist Therapeutics (NASDAQ:PTGX) Stock Rating Cut to "Buy" at Wall Street Zen - MarketBeat

Oct 10, 2026
pulisher
Oct 08, 2026

Protagonist Therapeutics, Inc. (PTGX) Stock forecasts - Yahoo Finance UK

Oct 08, 2026
pulisher
Oct 07, 2026

Protagonist Therapeutics, Inc. (PTGX) Stock Forecasts - Yahoo Finance

Oct 07, 2026
pulisher
Oct 05, 2026

Protagonist Therapeutics, Inc. (PTGX) Options Chain - Yahoo! Finance Canada

Oct 05, 2026
pulisher
Oct 04, 2026

Protagonist Therapeutics, Inc. (PTGX) Options Chain - Yahoo! Finance Canada

Oct 04, 2026
pulisher
Oct 03, 2026

Protagonist Therapeutics, Inc. (PTGX) options chain - Yahoo Finance Australia

Oct 03, 2026
pulisher
Oct 02, 2026

Protagonist Therapeutics(PTGX.US) Officer Sells US$8.31 Million in Common Stock - Moomoo

Oct 02, 2026
pulisher
Oct 02, 2026

Insider Selling: Protagonist Therapeutics (NASDAQ:PTGX) CFO Sells 58,629 Shares of Company Stock - MarketBeat

Oct 02, 2026
pulisher
Oct 02, 2026

After exercising options, Protagonist Therapeutics (PTGX) CFO sells 58,629 shares under a trading plan. - stocktitan.net

Oct 02, 2026
pulisher
Oct 02, 2026

Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Stock Has Consensus Price Target of $147.13 According to Analysts - MarketBeat

Oct 02, 2026
pulisher
Oct 01, 2026

Protagonist Therapeutics, Inc. (PTGX) Stock Forecasts - Yahoo Finance

Oct 01, 2026
pulisher
Oct 01, 2026

Form 144 PROTAGONIST THERAPEUTICS For: 1 October By Investing.com - Investing.com Nigeria

Oct 01, 2026
pulisher
Sep 30, 2026

Officer Asif Ali plans to sell 58,629 Protagonist Therapeutics (PTGX) shares. - Stock Titan

Sep 30, 2026
pulisher
Sep 28, 2026

Here's How Much $100 Invested In Protagonist Therapeutics 10 Years Ago Would Be Worth Today - Benzinga

Sep 28, 2026
pulisher
Sep 25, 2026

Protagonist Therapeutics (NASDAQ:PTGX) Shares Gap UpWhat's Next? - MarketBeat

Sep 25, 2026
pulisher
Sep 22, 2026

Top Generate Biomedicines (GENB) Competitors 2026 - MarketBeat

Sep 22, 2026
pulisher
Sep 21, 2026

Protagonist Therapeutics (Nasdaq:PTGX)Stock Analysis - simplywall.st

Sep 21, 2026
pulisher
Sep 18, 2026

1,324,498 Shares in Protagonist Therapeutics, Inc. $PTGX Purchased by Bank of America Corp DE - MarketBeat

Sep 18, 2026
pulisher
Sep 16, 2026

PTGX: Protagonist Therapeutics Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits

Sep 16, 2026
pulisher
Sep 15, 2026

Protagonist Therapeutics (NASDAQ:PTGX) Combines High Growth Momentum With a Breakout Setup - ChartMill

Sep 15, 2026
pulisher
Sep 13, 2026

VIRGINIA RETIREMENT SYSTEMS ET Al Buys Shares of 11,200 Protagonist Therapeutics, Inc. $PTGX - MarketBeat

Sep 13, 2026
pulisher
Sep 12, 2026

(PTGX) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

Sep 12, 2026
pulisher
Sep 11, 2026

Protagonist Therapeutics CEO sells $18.2m in shares By Investing.com - Investing.com Australia

Sep 11, 2026
pulisher
Sep 11, 2026

Hsbc Holdings PLC Purchases 24,045 Shares of Protagonist Therapeutics, Inc. $PTGX - MarketBeat

Sep 11, 2026
pulisher
Sep 11, 2026

Protagonist Therapeutics Insider Sold Shares Worth $18,240,568, According to a Recent SEC Filing - Yahoo Finance

Sep 11, 2026
pulisher
Sep 10, 2026

Dinesh Ph Patel Sells 63,548 Shares of Protagonist Therapeutics (NASDAQ:PTGX) Stock - MarketBeat

Sep 10, 2026
pulisher
Sep 10, 2026

Insider Selling: Protagonist Therapeutics (NASDAQ:PTGX) CEO Sells 54,174 Shares - MarketBeat

Sep 10, 2026
pulisher
Sep 10, 2026

Protagonist Therapeutics CEO sells $18.2m in shares - Investing.com India

Sep 10, 2026
pulisher
Sep 10, 2026

Protagonist Therapeutics CEO sells $18.2m in shares By Investing.com - Investing.com UK

Sep 10, 2026
pulisher
Sep 10, 2026

Protagonist Therapeutics (PTGX) CEO sells 125K shares in preset plan - Stock Titan

Sep 10, 2026
pulisher
Sep 10, 2026

Protagonist Therapeutics(PTGX.US) Officer Sells US$18.24 Million in Common Stock - Moomoo

Sep 10, 2026
pulisher
Sep 10, 2026

Protagonist Therapeutics at Cantor conference: cash, launches and pipeline By Investing.com - Investing.com Nigeria

Sep 10, 2026
pulisher
Sep 10, 2026

Protagonist Therapeutics at Cantor conference: cash, launches and pipeline By Investing.com - Investing.com UK

Sep 10, 2026
pulisher
Sep 09, 2026

Protagonist Therapeutics, Inc. at Citi Biopharma Back to School Summit Transcript - GuruFocus

Sep 09, 2026
pulisher
Sep 09, 2026

Transcript : Protagonist Therapeutics, Inc. Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-09-2026 10 - marketscreener.com

Sep 09, 2026
pulisher
Sep 08, 2026

Protagonist Therapeutics authorizes $300 million buyback plan By Investing.com - Investing.com Nigeria

Sep 08, 2026
pulisher
Sep 08, 2026

Protagonist Therapeutics authorizes $300 million buyback plan By Investing.com - Investing.com South Africa

Sep 08, 2026
pulisher
Sep 08, 2026

Protagonist Therapeutics (PTGX) CEO gifts stock to family - Stock Titan

Sep 08, 2026
pulisher
Sep 08, 2026

Protagonist Therapeutics authorizes $300 million buyback plan - investing.com

Sep 08, 2026
pulisher
Sep 08, 2026

Protagonist Therapeutics Announces $300 Million Share Repurchase Program - ACCESS Newswire

Sep 08, 2026
pulisher
Sep 08, 2026

Protagonist Therapeutics Announces $300 Million Share Repurchase Program - chronicle-tribune.com

Sep 08, 2026
pulisher
Sep 08, 2026

Protagonist Therapeutics Announces $300 Million Share Repurchase Program - marketscreener.com

Sep 08, 2026

Protagonist Therapeutics Inc (PTGX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Protagonist Therapeutics Inc (PTGX) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
ASIF ALI
Officer
Sep 30 '26
Proposed Sale
140.97
58,629
8,264,930
0
Ali Asif
Chief Financial Officer
Sep 30 '26
Sale
141.78
58,629
8,312,294
59,003
PATEL DINESH V PH D
President and CEO
Sep 10 '26
Sale
144.10
7,278
1,048,760
522,968
PATEL DINESH V PH D
President and CEO
Sep 10 '26
Option Exercise
21.58
7,278
157,059
530,246
PATEL DINESH V PH D
President and CEO
Sep 09 '26
Option Exercise
21.58
63,548
1,371,366
586,516
PATEL DINESH V PH D
President and CEO
Sep 09 '26
Sale
146.18
63,548
9,289,447
522,968
PATEL DINESH V PH D
President and CEO
Sep 08 '26
Sale
145.87
54,174
7,902,361
522,968
PATEL DINESH V PH D
President and CEO
Sep 08 '26
Option Exercise
21.58
54,174
1,169,075
577,142
PATEL DINESH V PH D
President and CEO
Aug 11 '26
Sale
148.52
34,239
5,085,176
523,478
PATEL DINESH V PH D
President and CEO
Aug 11 '26
Option Exercise
21.58
34,239
738,878
557,717
$53.97
price down icon 3.62%
$157.14
price down icon 2.87%
$61.95
price down icon 3.08%
CAI CAI
$30.56
price down icon 3.78%
$104.78
price down icon 3.11%
$55.90
price down icon 4.44%
大文字化:     |  ボリューム (24 時間):